RAIGAD/MUMBAI – Sparking a mega health scare, at least 90 Covid-19 patients in Maharashtra’s Raigad district, who were administered Remdesivir doses of a particular brand, developed severe side ...

Two widows in the Inland Empire are suing Kaiser Permanente and Redlands Community Hospital for using Remdesivir to treat their husbands' COVID-19 diagnoses. "I am a widow and I am 52," said widow ...

Please provide your email address to receive an email when new articles are posted on . However, earlier reports failed to address the antiviral effects of remdesivir and hydroxychloroquine, Andreas ...

Using propensity score matching, the drug duo was associated with an overall 26% reduction in mortality at 14 days (adjusted HR 0.74, 95% CI 0.69-0.78, P<0.0001) and an overall 24% reduction at 28 ...

Gilead’s Covid-19 drug remdesivir appeared to reduce hospitalizations by 87% in high-risk patients diagnosed early in the disease in a new study, the company said Wednesday. The new results, which ...

FOSTER CITY, Calif. - Gilead Sciences said its anti-viral drug Veklury, also known as remdesivir, has shown promise in lowering the risk of hospitalization among certain COVID-19 patients. Data from ...

In a recent study posted to the bioRxiv* preprint server, researchers assessed the cardiac effects of remdesivir. Study: Activation of the urotensin-II receptor by anti-COVID-19 drug remdesivir ...

The GS-441524 Remdesivir metabolite alongside ADP-ribose; HCV drug BOC binding to the NSP5 protease binding pocket. In the search for new ways to use small molecule drugs to prevent and treat Covid-19 ...